Navigation Links
Tucson Symposium attracts over 450 global scientists focused on personalized healthcare
Date:3/8/2013

TUCSON, Ariz., March 8, 2013 /PRNewswire/ -- For millions of patients, personalized healthcare, or fitting the right treatments to patients based on an individual's particular genetic make-up, means the difference between life and death. Our expanding knowledge of disease mechanisms and individual genetic variation, along with advanced testing technologies enables physicians to provide more precise diagnoses and targeted treatments for all patients, especially cancer patients.

Ventana Medical Systems, Inc. (Ventana), whose mission is to improve the lives of all patients afflicted with cancer, has been on the leading edge of the personalized healthcare revolution. Hosting the ninth annual Tucson Symposium--attended by over 450 of the world's top scientists, physicians and thought leaders in the field of pathology and oncology--underscores their deep commitment to setting entirely new standards for patient care.

The 2013 Symposium will focus on the latest advancements in personalized healthcare including new technologies that enhance patient diagnosis, understanding mechanisms of disease resistance, and the pathology of DNA repair— along with the latest findings in specific types of cancers including colon, breast, lung, prostate, cervical, ovarian, and melanoma.

"It becomes increasingly evident effective cancer treatment requires the use of particularly powerful combinations of cancer drugs. But which of the many possible drug combinations should be used for the treatment of an individual patient?

Recent developments in genetic technologies have greatly expedited the search for powerful drug combinations in oncology. This holds great promise for the future treatment of cancer," says Rene Bernards, Professor of Molecular Carcinogenesis at the Netherlands Cancer Institute in Amsterdam, The Netherlands.

"In recent years, the Tucson S
'/>"/>

SOURCE Ventana Medical Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mesothelioma Symposium Gains Dedicated, Passionate Sponsor in the Nemeroff Law Firm
2. Leading Breast Surgeons Highlight Techniques and Visualization Technologies for Improved Clinical and Aesthetic Outcomes at Invuitys Surgeon Educational Symposium
3. Physical & Mental Health of Women in the Military to be Addressed at 2013 iaedp Symposium
4. Registration now open for StemCONN 2013 stem cell symposium April 3, 2013 in New Haven, CT
5. MetaStat Announces Presentations at the 2012 San Antonio Breast Cancer Symposium
6. Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
7. US HIFU Technology Featured At Third International Symposium on Focused Ultrasound
8. Henry Schein Announces Featured Speakers For The "Recovery Empowerment Symposium: Emerging From The Storm"
9. Henry Schein To Convene Expert-Led Symposium On Practice Recovery In The Wake Of Hurricane Sandy
10. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
11. Comprehensive Spine Symposium: Sept. 21
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
(Date:1/14/2014)... a manufacturer of ergonomically designed laboratory equipment for research, ... Japan to sell and service the Hitachi brand ... utilize its network of sales professionals throughout the United ... assistance in application use, product benefits and features, options and accessories, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... First Commercial Market to Demonstrate Test,s Potential for ... ... ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI ) today,announced ... The test searches for a unique gene expression signature,identified by DiaGenic using ...
... Drug was Well-Tolerated, Significantly Inhibited ... on Monday, November 10 at 8:30 ... a.m. ET-, ... VIAP ), a biotechnology company focused on,the development of compounds for the treatment ...
Cached Medicine Technology:Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test 2Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test 3VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 2VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 3VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 4VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 5VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 6VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 7VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 8
(Date:4/18/2014)... Harvard neuroscientists have made a discovery that turns 160 ... electrical insulating material long known to be essential for ... nerve cells, is not as ubiquitous as thought, according ... of the Harvard Stem Cell Institute (HSCI) and the ... collaboration with Professor Jeff Lichtman, of Harvard,s Department of ...
(Date:4/18/2014)... your worst memories? How did it make you feel? ... negative personal experience, such as how sad you were ... distress, especially when you can,t stop thinking about it. ... about the context of the memories, rather than how ... to alleviate the negative effects of these memories, a ...
(Date:4/18/2014)... Simon Fraser University psychologists have made a brain-related ... of attention-deficit disorders. , This discovery opens up ... hinder or suppress a specific brain activity that ... distraction. , The Journal of Neuroscience ... by John McDonald, an associate professor of psychology ...
(Date:4/18/2014)... is available in French . ... surgical practice and regenerative medicine. A team led by ... (CNRS/ESPCI Paris Tech) and Didier Letourneur from the Laboratoire ... has just demonstrated that the principle of adhesion by ... to repair soft-tissue organs and tissues. This easy-to-use gluing ...
(Date:4/17/2014)... inflammation in benign prostate tissue was associated with ... was found even in those with low prostate-specific ... in Cancer Epidemiology, Biomarkers & Prevention , ... Research. , An analysis of prostate tissue biopsies ... of the Prostate Cancer Prevention Trial (PCPT) found ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Scientists discover brain's anti-distraction system 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3
... potential role of Eph receptor and ephrin ligand family ... other Eph receptors, EphA4 is distinguished by its ability ... type B ephrins. EphA4 reportedly forms a hetero receptor ... downstream signal transduction. However, alterations of EphA4 are not ...
... association of DM2 with solid tumors, and particularly with ... reported increased mortality rates for neoplastic diseases in patients ... diabetes and development of HCC, and the clinical and ... not been well examined. , A research article to ...
... 29 Abbott (NYSE: ABT ),will present at ... Nov. 12. Thomas C. Freyman, executive vice president, finance,and ... company at 5,p.m. CST., A live audio webcast ... Web site at http://www.abbottinvestor.com . An,archived edition of ...
... PRUSSIA, Pa., Oct. 29 HighPoint,Solutions LLC, a premier ... of its growth strategy, it has expanded its,presence in ... new location will,be at 8750 W. Bryn Mawr, Suite ... located near O,Hare International,Airport., Glenn Becker, HighPoint Solutions, ...
... N.J., Oct. 29 Derma Sciences, Inc.,(OTC Bulletin Board: ... it will present at the upcoming Rodman & Renshaw ... Palace Hotel in,New York City. The Company is scheduled ... Adams room located on the 4th floor., Management ...
... Drive Company,s Latest Learning Technology, ORLANDO, Fla., ... a leading provider of educational enterprise technology,announced today ... Release 9.0,featuring nearly 50 institutions that are now ... of the Beta program are evaluating and providing ...
Cached Medicine News:Health News:If the diabetes has a direct carcinogenetic effect? 2Health News:HighPoint Solutions Expands with New Chicago Office 2Health News:Derma Sciences to Present at The Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:Blackboard Announces Launch of Beta Program 2Health News:Blackboard Announces Launch of Beta Program 3Health News:Blackboard Announces Launch of Beta Program 4
Used for emergency airway access when endotracheal intubation cannot be performed. Supplied sterile in peel-open packages. Intended for one-time use....
Used for emergency airway access when conventional endotracheal intubation cannot be performed....
... Standard/Conventional. Stainless steel. Lamp supplied with ... high quality standard incandescent laryngoscope blades. The ... refined through many years of use the ... are manufactured to exacting specifications from the ...
... Blade. Stainless Steel. Lamp supplied with ... of high quality standard incandescent laryngoscope ... have been continually refined through many ... to minimize maintenance requirements. They are ...
Medicine Products: